45 Result(s)

Article

Modern Management of Cardiometabolic Continuum: From Overweight/Obesity to Prediabetes/Type 2 Diabetes Mellitus. Recommendations from the Eastern and Southern Europe Diabetes and Obesity Expert Group

The increasing global incidence of obesity and type 2 diabetes mellitus (T2D) underscores the urgency of addressing these interconnected health challenges. Obesity enhances genetic and environmental influences...

Andrej Janez, Emir Muzurovic, Pawel Bogdanski, Leszek Czupryniak… in Diabetes Therapy (2024)

Article

The Effect of Sodium–Glucose Cotransporter Inhibitors on Renal Function as Adjunctive to Insulin in Adults with Type 1 Diabetes: An Updated Multilevel Meta-analysis of Randomized Controlled Trials

This systematic review aimed to summarize the existing evidence from published randomized controlled trials (RCTs) on the impact of sodium–glucose cotransporter (SGLT) inhibitors on albuminuria levels and rena...

Paschalis Karakasis, Djordje S. Popovic, Dimitrios Patoulias… in Diabetes Therapy (2024)

Article

Correction to: New-Onset Diabetes Mellitus in COVID-19: A Sco** Review

Anca Pantea Stoian, Ioana-Cristina Bica, Teodor Salmen, Wael Al Mahmeed… in Diabetes Therapy (2024)

Article

New-Onset Diabetes Mellitus in COVID-19: A Sco** Review

The coronavirus disease 2019 (COVID-19) pandemic became superimposed on the pre-existing obesity and diabetes mellitus (DM) pandemics. Since COVID-19 infection alters the metabolic equilibrium, it may induce p...

Anca Pantea Stoian, Ioana-Cristina Bica, Teodor Salmen, Wael Al Mahmeed… in Diabetes Therapy (2024)

Article

Neurological Consequences, Mental Health, Physical Care, and Appropriate Nutrition in Long-COVID-19

SARS-CoV-2 pandemic has caused a collapse of the world health systems. Now, vaccines and more effective therapies have reversed this crisis but the scenario is further aggravated by the appearance of a new pat...

Pasquale Picone, Tiziana Sanfilippo… in Cellular and Molecular Neurobiology (2023)

Article

Semaglutide in Obesity: Unmet Needs in Men

Mojca Jensterle, Manfredi Rizzo, Andrej Janež in Diabetes Therapy (2023)

Article

Absolute Hyperglycemia versus Stress Hyperglycemia Ratio for the Prognosis of Hospitalized Patients with COVID-19 in the First Months of the Pandemic: A Retrospective Study

Diabetes is a risk factor for greater severity of coronavirus disease 2019 (COVID-19). The stress hyperglycemia ratio (SHR) is an independent predictor of critical illness, and it is reported to have a stronge...

Alexandra A. Matias, Inês Manique, Teresa Sabino, Teresa Rego… in Diabetes Therapy (2023)

Article

Use of glucagon in severe hypoglycemia is scarce in most countries, and has not been expanded by new ready-to-use glucagons

Glucagon (traditional kits for intramuscular administration, Glucagon and Glucagen), although recommended as a remedy for severe hypoglycemia (SH), has been reported to be under-utilized, likely because of tec...

Antonio E. Pontiroli, Manfredi Rizzo, Elena Tagliabue in Diabetology & Metabolic Syndrome (2022)

Article

Personalized management of dyslipidemias in patients with diabetes—it is time for a new approach (2022)

Dyslipidemia in patients with type 2 diabetes (DMT2) is one of the worst controlled worldwide, with only about 1/4 of patients being on the low-density lipoprotein cholesterol (LDL-C) target. There are many re...

Maciej Banach, Stanisław Surma, Zeljko Reiner, Niki Katsiki… in Cardiovascular Diabetology (2022)

Article

The Dual Pandemics of COVID-19 and Obesity: Bidirectional Impact

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), responsible for the COVID-19 pandemic, has been shown to disrupt many organ systems in the human body. Though several medical disorders have be...

Nitin Kapoor, Sanjay Kalra, Wael Al Mahmeed, Khalid Al-Rasadi… in Diabetes Therapy (2022)

Article

Efficacy of GLP-1 RA Approved for Weight Management in Patients With or Without Diabetes: A Narrative Review

The approval of once daily liraglutide, 3.0 mg, and once weekly semaglutide, 2.4 mg, for chronic weight management provides a novel effective strategy against obesity. The reliable models that might predict we...

Mojca Jensterle, Manfredi Rizzo, Martin Haluzík, Andrej Janež in Advances in Therapy (2022)

Article

Effect of Oral Semaglutide on Cardiovascular Parameters and Their Mechanisms in Patients with Type 2 Diabetes: Rationale and Design of the Semaglutide Anti-Atherosclerotic Mechanisms of Action Study (SAMAS)

Type 2 diabetes (T2D) management has reached a point where not only optimal glycaemic control is necessary, but also additional interventions with proven cardiovascular risk reduction benefit. Subcutaneous sem...

Miodrag Janić, Manfredi Rizzo, Francesco Cosentino, Anca Pantea Stoian… in Diabetes Therapy (2022)

Article

Liraglutide Improved Cardiometabolic Parameters More in Obese than in Non-obese Patients with Type 2 Diabetes: A Real-World 18-Month Prospective Study

The glucagon-like peptide-1 agonist (GLP1-RA) liraglutide is currently approved for the treatment of both obesity and type 2 diabetes (T2DM). We investigated whether the effect of this agent on cardiometabolic...

Dragana Nikolic, Angelo M. Patti, Rosaria V. Giglio, Roberta Chianetta… in Diabetes Therapy (2022)

Article

Glycemic Variability, Glycated Hemoglobin, and Cardiovascular Complications: Still a Dilemma in Clinical Practice

Antonio Ceriello, Ali A. Rizvi, Manfredi Rizzo in Advances in Therapy (2022)

Article

Use of Novel Antidiabetic Agents in Patients with Type 2 Diabetes and COVID-19: A Critical Review

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes coronavirus disease 2019 (COVID-19). The latter is a pandemic that has the potential of develo** into a severe illness manifesting as syste...

Djordje S. Popovic, Nikolaos Papanas, Anca Pantea Stoian, Ali A. Rizvi… in Diabetes Therapy (2021)

Article

Nutraceuticals in the Management of Dyslipidemia: Which, When, and for Whom? Could Nutraceuticals Help Low-Risk Individuals with Non-optimal Lipid Levels?

The aim of this review is to summarize the available clinical efficacy and safety data related to the most studied and used lipid-lowering nutraceuticals.

Arrigo F. G. Cicero, Federica Fogacci… in Current Atherosclerosis Reports (2021)

Article

New Sub-Phenoty** of Subjects at High Risk of Type 2 Diabetes: What Are the Potential Clinical Implications?

Prediabetes is defined as a condition of abnormal glucose metabolism, characterised by plasma glucose above normal range but not as high as required for the diagnosis of diabetes mellitus (DM). It represents a...

Djordje S. Popovic, Manfredi Rizzo, Edita Stokic, Nikolaos Papanas in Diabetes Therapy (2021)